Table of Content

1 Study Coverage
1.1 Parkinson's Disease Drug Product Introduction
1.2 Market by Type
1.2.1 Global Parkinson's Disease Drug Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
1.3 Market by Application
1.3.1 Global Parkinson's Disease Drug Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
1.4 Global Parkinson's Disease Drug Market by Region
1.4.1 Global Parkinson's Disease Drug Market by Region: 2019 VS 2024 VS 2030
1.4.2 Global Parkinson's Disease Drug Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Parkinson's Disease Drug Revenue by Players
2.1.1 Global Parkinson's Disease Drug Revenue by Players (2019-2024)
2.1.2 Global Parkinson's Disease Drug Revenue Market Share by Players (2019-2024)
2.1.3 Global Top 5 and Top 10 Companies by Parkinson's Disease Drug Revenue in 2024
2.2 Global Parkinson's Disease Drug Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Parkinson's Disease Drug Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Merck
3.1.1 Merck Information
3.1.2 Merck Overview
3.1.3 Merck Parkinson's Disease Drug Revenue and Gross Margin (2019-2024)
3.1.4 Merck Related Developments
3.2 Akorn
3.2.1 Akorn Information
3.2.2 Akorn Overview
3.2.3 Akorn Parkinson's Disease Drug Revenue and Gross Margin (2019-2024)
3.2.4 Akorn Related Developments
3.3 GSK
3.3.1 GSK Information
3.3.2 GSK Overview
3.3.3 GSK Parkinson's Disease Drug Revenue and Gross Margin (2019-2024)
3.3.4 GSK Related Developments
3.4 Novartis
3.4.1 Novartis Information
3.4.2 Novartis Overview
3.4.3 Novartis Parkinson's Disease Drug Revenue and Gross Margin (2019-2024)
3.4.4 Novartis Related Developments
3.5 Boehringer Ingelheim
3.5.1 Boehringer Ingelheim Information
3.5.2 Boehringer Ingelheim Overview
3.5.3 Boehringer Ingelheim Parkinson's Disease Drug Revenue and Gross Margin (2019-2024)
3.5.4 Boehringer Ingelheim Related Developments
3.6 Teva Pharmaceutical
3.6.1 Teva Pharmaceutical Information
3.6.2 Teva Pharmaceutical Overview
3.6.3 Teva Pharmaceutical Parkinson's Disease Drug Revenue and Gross Margin (2019-2024)
3.6.4 Teva Pharmaceutical Related Developments
3.7 Abbvie
3.7.1 Abbvie Information
3.7.2 Abbvie Overview
3.7.3 Abbvie Parkinson's Disease Drug Revenue and Gross Margin (2019-2024)
3.7.4 Abbvie Related Developments
3.8 Kyowa Hakko Kirin Pharma
3.8.1 Kyowa Hakko Kirin Pharma Information
3.8.2 Kyowa Hakko Kirin Pharma Overview
3.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Revenue and Gross Margin (2019-2024)
3.8.4 Kyowa Hakko Kirin Pharma Related Developments
3.9 Astellas Pharma
3.9.1 Astellas Pharma Information
3.9.2 Astellas Pharma Overview
3.9.3 Astellas Pharma Parkinson's Disease Drug Revenue and Gross Margin (2019-2024)
3.9.4 Astellas Pharma Related Developments
3.10 Desitin Arzneimittel
3.10.1 Desitin Arzneimittel Information
3.10.2 Desitin Arzneimittel Overview
3.10.3 Desitin Arzneimittel Parkinson's Disease Drug Revenue and Gross Margin (2019-2024)
3.10.4 Desitin Arzneimittel Related Developments
3.11 Endo Pharmaceuticals
3.11.1 Endo Pharmaceuticals Information
3.11.2 Endo Pharmaceuticals Overview
3.11.3 Endo Pharmaceuticals Parkinson's Disease Drug Revenue and Gross Margin (2019-2024)
3.11.4 Endo Pharmaceuticals Related Developments
4 Global Parkinson's Disease Drug Market Insights
4.1 Global Parkinson's Disease Drug Market Revenue 2019-2024
4.2 Global Parkinson's Disease Drug Revenue by Region
4.3 Americas
4.4 Europe
4.5 Asia-Pacific
4.6 Middle East & Africa
5 Market Size by Type
5.1 Global Parkinson's Disease Drug Revenue by Type
5.2 Global Parkinson's Disease Drug Market Size Growth by Type 2019-2024
6 Market Size by Application
6.1 Global Parkinson's Disease Drug Revenue by Application
6.2 Global Parkinson's Disease Drug Market Size Growth by Application 2019-2024
7 Americas
7.1 Americas Parkinson's Disease Drug Market Size by Type
7.1.1 Americas Parkinson's Disease Drug Revenue by Type (2019-2024)
7.1.2 Americas Parkinson's Disease Drug Revenue Share by Type (2019-2024)
7.2 Americas Parkinson's Disease Drug Market Size by Application
7.2.1 Americas Parkinson's Disease Drug Revenue by Application (2019-2024)
7.2.2 Americas Parkinson's Disease Drug Revenue Share by Application (2019-2024)
7.3 Americas Parkinson's Disease Drug Market Size by Country
7.3.1 Americas Parkinson's Disease Drug Revenue by Country (2019-2024)
7.3.2 U.S.
7.3.3 Canada
7.3.4 Mexico
7.3.5 Brazil
7.3.6 Argentina
8 Europe
8.1 Europe Parkinson's Disease Drug Market Size by Type
8.1.1 Europe Parkinson's Disease Drug Revenue by Type (2019-2024)
8.1.2 Europe Parkinson's Disease Drug Revenue Share by Type (2019-2024)
8.2 Europe Parkinson's Disease Drug Market Size by Application
8.2.1 Europe Parkinson's Disease Drug Revenue by Application (2019-2024)
8.2.2 Europe Parkinson's Disease Drug Revenue Share by Application (2019-2024)
8.3 Europe Parkinson's Disease Drug Market Size by Country
8.3.1 Europe Parkinson's Disease Drug Revenue by Country (2019-2024)
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
9 Asia Pacific
9.1 Asia Pacific Parkinson's Disease Drug Market Size by Type
9.1.1 Asia Pacific Parkinson's Disease Drug Revenue by Type (2019-2024)
9.1.2 Asia Pacific Parkinson's Disease Drug Revenue Share by Type (2019-2024)
9.2 Asia Pacific Parkinson's Disease Drug Market Size by Application
9.2.1 Asia Pacific Parkinson's Disease Drug Revenue by Application (2019-2024)
9.2.2 Asia Pacific Parkinson's Disease Drug Revenue Share by Application (2019-2024)
9.3 Asia Pacific Parkinson's Disease Drug Market Size by Region
9.3.1 Asia Pacific Parkinson's Disease Drug Revenue by Region (2019-2024)
9.3.2 China
9.3.3 Japan
9.3.4 South Korea
9.3.5 India
9.3.6 Southeast Asia
9.3.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Parkinson's Disease Drug Market Size by Type
10.1.1 Middle East and Africa Parkinson's Disease Drug Revenue by Type (2019-2024)
10.1.2 Middle East and Africa Parkinson's Disease Drug Revenue Share by Type (2019-2024)
10.2 Middle East and Africa Parkinson's Disease Drug Market Size by Application
10.2.1 Middle East and Africa Parkinson's Disease Drug Revenue by Application (2019-2024)
10.2.2 Middle East and Africa Parkinson's Disease Drug Revenue Share by Application (2019-2024)
10.3 Middle East and Africa Parkinson's Disease Drug Market Size by Country
10.3.1 Middle East and Africa Parkinson's Disease Drug Revenue by Country (2019-2024)
10.3.2 Turkey
10.3.3 Saudi Arabia
10.3.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Parkinson's Disease Drug Industry Trends
11.2 Parkinson's Disease Drug Market Drivers
11.3 Parkinson's Disease Drug Market Challenges
11.4 Parkinson's Disease Drug Market Restraints
12 Parkinson's Disease Drug Forecasted Market Size by Type
12.1 Global Parkinson's Disease Drug Forecasted Revenue by Type
12.2 Global Parkinson's Disease Drug Forecasted Market Size Growth by Type 2024-2030
13 Parkinson's Disease Drug Forecasted Market Size by Application
13.1 Global Parkinson's Disease Drug Forecasted Revenue by Application
13.2 Global Parkinson's Disease Drug Forecasted Market Size Growth by Application 2024-2030
14 Global Parkinson's Disease Drug Market Forecasts
14.1 Global Parkinson's Disease Drug Market Revenue Forecasts 2024-2030
14.2 Global Parkinson's Disease Drug Forecasts Revenue by Region
14.3 Americas
14.3.1 Americas Parkinson's Disease Drug Forecasts Revenue by Country (2019-2024)
14.4 Europe
14.4.1 Europe Parkinson's Disease Drug Forecasts Revenue by Country (2019-2024)
14.5 Asia-Pacific
14.5.1 Asia Pacific Parkinson's Disease Drug Forecasts Revenue by Country (2019-2024)
14.6 Middle East & Africa
14.6.1 Middle East and Africa Parkinson's Disease Drug Forecasts Revenue by Country (2019-2024)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer